This technical report defines the U131-Kampo Generalized Structural Screening Framework, extending the earlier active6 Kampo structural classifier into a cross-corpus botanical and compound-network governance model. The framework preserves active6 + official148 as the committed Kampo baseline while maintaining official180/official200 as candidates, shadow294 as a non-committed formula ledger, Herb500 as a governed material ledger, and Herb1000 as a stress-only set.The report formalizes normalized material records, compound and biosynthesis proxies, target-protein proxies, a non-predictive K48 finite geometric index, codon-amino-acid annotation layers, candidate-priority scoring, risk quarantine, no-call routing, blind candidate freeze rules, and external validation replay slots. Across the v1601-v2000 audit segment, 62,640 of 62,640 computational governance checks passed.This work is intended as a mathematical and algorithmic structural-screening scaffold for pre-experimental candidate prioritization. It does not make claims about clinical efficacy, prescribing, dosage guidance, human safety, human use, or drug approval.
Takada et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: